Modelling how increased Cathepsin B/L and decreased TMPRSS2 usage for cell entry by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and Cathepsin B/L inhibitors (Q6078351)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Modelling how increased Cathepsin B/L and decreased TMPRSS2 usage for cell entry by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and Cathepsin B/L inhibitors |
scientific article; zbMATH DE number 7742802
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Modelling how increased Cathepsin B/L and decreased TMPRSS2 usage for cell entry by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and Cathepsin B/L inhibitors |
scientific article; zbMATH DE number 7742802 |
Statements
Modelling how increased Cathepsin B/L and decreased TMPRSS2 usage for cell entry by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and Cathepsin B/L inhibitors (English)
0 references
27 September 2023
0 references
SARS-CoV-2
0 references
COVID-19
0 references
Omicron
0 references
spike protein
0 references
TMPRSS2
0 references
Cathepsin
0 references
mathematical modelling
0 references
viral kinetics
0 references
drug synergy
0 references
